Summit Therapeutics (SUMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 28.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 215.00
  • 52 Week Low: 27.03
  • Currency: UK Pounds
  • Shares Issued: 82.13m
  • Volume: 7,905
  • Market Cap: 23.41m
  • RiskGrade: 730

SUMM Overview

Summit Therapeutics is in the pharma and biotech sector and is currently trading at 28.50p per share. In the last year Summit Therapeutics 's share price has ranged from 27.03p to 215.00p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -50.4% n/a
ROCE 4748.1%  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 0.9 n/a
Pr/Book 2.4  
Latest F'cast
Revenue 1005.2% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SUMM Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Jan-14 1.38 (6.70) (30.00)p n/a n/a n/a n/a 0.0%
31-Jan-15 1.17 (12.66) (29.00)p n/a n/a n/a n/a 0.0%
31-Jan-16 n/a (23.20) (34.00)p n/a n/a n/a n/a 0.0%
31-Jan-17 2.30 (25.71) (35.00)p n/a n/a n/a n/a 0.0%
31-Jan-18 25.42 (10.89) (11.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SUMM Company Announcements

Summit Reports Financial Results for the Second ... 20-Sep-2018 12:00 GlobeNewswire NA
Summit Therapeutics to Present at the Rodman & R... 29-Aug-2018 12:00 GlobeNewswire EU
Summit Awarded Additional $12 Million by BARDA f... 16-Aug-2018 12:00 GlobeNewswire EU

Latest SUMM Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

SUMM Market Data

Currency UK Pounds
Share Price 28.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 215.00
52 Week Low 27.03
Volume 7,905
Shares Issued 82.13m
Market Cap 23.41m
RiskGrade 730

SUMM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.05% below the market average17.05% below the market average17.05% below the market average17.05% below the market average17.05% below the market average
36.67% below the sector average36.67% below the sector average36.67% below the sector average36.67% below the sector average36.67% below the sector average
Price Trend
99.23% below the market average99.23% below the market average99.23% below the market average99.23% below the market average99.23% below the market average
96.72% below the sector average96.72% below the sector average96.72% below the sector average96.72% below the sector average96.72% below the sector average
Income Not Available
Growth
22.74% above the market average22.74% above the market average22.74% above the market average22.74% above the market average22.74% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

SUMM Dividends

No dividends found

Trades for 17-Oct-2018

Time Volume / Share Price
16:16 3,000 @ 27.03p
12:51 3,448 @ 29.00p
12:39 500 @ 29.00p
12:23 841 @ 29.00p
08:00 52 @ 27.03p

SUMM Key Personnel

CEO Glyn Edwards
COO David Roblin

Top of Page